EFFICACY AND SAFETY OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACROSS THE SPECTRUM OF FRAILTY
Back
Abstract Number
WCN23-0666
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Other CKD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
EFFICACY AND SAFETY OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACROSS THE SPECTRUM OF FRAILTY
Co-authors
Vart, P.(1);Butt, J.(2);Niels, J.(1);Chertow, G.M.(3);Wheeler, D.C.(4);Mcmurray, J.J.V.(2);Langkilde, A.M.(5);Lambers Heerspink, H.(1)*;
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)University Of Groningen- University Medical Center Groningen, Department Of Clinical Pharmacy And Pharmacology, Groningen, Netherlands;(2)University Of Glasgow, Institute Of Cardiovascular And Medical Sciences, Glasgow, United Kingdom;(3)Stanford University School Of Medicine, Department Of Medicine, Stanford, United States;(4)University College London, Department Of Renal Medicine, London, United Kingdom;(5)Astrazeneca, Biopharmaceuticals R&D, Gothenburg, Sweden;
E-Poster
https://storage.unitedwebnetwork.com/files/184/22fb334b57fce950ba59237e4e5c268c.pdf
Audio File
if any